Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...